MIRM
Mirum Pharmaceuticals, Inc.
Stock
$82.93−0.99 (−1.18%)Close Oct 2, 2026
- Research and development, 2025
- $186M
- YoY, 2025
- +32.4%
- 5-year CAGR
- +17.9%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $186M | +32.4% |
| 2024 | $141M | +37.1% |
| 2023 | $103M | −4.0% |
| 2022 | $107M | −18.7% |
| 2021 | $131M | +61.1% |
| 2020 | $82M | +89.8% |
| 2019 | $43M | — |